DETECTION KITS SYSTEMS

Brand Owner (click to sort) Address Description
BIOLOGICAL DEFENSE SYSTEMS INVITROGEN CORPORATION 1600 FARADAY AVENUE CARLSBAD CA 92008 detection kits and systems for airborne, food-borne and water-borne pathogens; integrated high throughput target screening technologies to support vaccine, therapeutic and diagnostic development; research reagents, cloning vectors, genes, diagnostic and detection agents, antibodies, all for laboratory and scientific research;integrated high throughput target screening services to support vaccine, therapeutic and diagnostic development; research and development services to accelerate the production of vaccines, diagnostic tests and therapies; vaccine construction for others; production of custom reagents, chips, arrays, and gene cloning for others; detection and identification of toxins and agents for others;
BIOLOGICAL DEFENSE SYSTEMS AND DESIGN INVITROGEN CORPORATION 1600 FARADAY AVENUE CARLSBAD CA 92008 detection kits and systems for airborne, food-borne and water-borne pathogens; integrated high throughput target screening technologies to support vaccine, therapeutic and diagnostic development; research reagents, cloning vectors, genes, diagnostic and detection agents, antibodies, all for laboratory and scientific research;integrated high throughput target screening services to support vaccine, therapeutic and diagnostic development; research and development services to accelerate the production of vaccines, diagnostic tests and therapies; vaccine construction for others; production of custom reagents, chips, arrays, and gene cloning for others; detection and identification of toxins and agents for others;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Method and kits are provided for the detection and diagnosis of metastatic disease. More particularly, the methods and kits employ compounds that can detect EphA2, a specific epithelial cell tyrosine kinase that is overexpressed in metastatic tumor cells. In one embodiment the compound is an antibody capable of binding to an epitope of EphA2.